在抗体CH2域中的L309K突变的药物适应性特性

Cui Li1, Qing-Qing Yao2, Jiang Li1

  • 1Department of Pharmacy, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310000 Zhejiang China.

3 Biotech
|May 14, 2024
PubMed
概括

通过减少聚合和改善物理化学性质,L309K突变增强了抗体的药物可用性. 这种抗体工程策略维持生物功能,同时提高稳定性和减少不必要的Fc受体相互作用.